View in EDS

Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.

Saved in:
Bibliographic Details
Title: Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.
Authors: Vidal-Sabanés M; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Navaridas R; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA., Bonifaci N; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain., Gay-Rua A; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Ortega-Peinado D; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Egea J; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Encinas M; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Matias-Guiu X; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.; Oncologic Pathology Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Llobet-Navas D; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain., Dolcet X; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.
Source: Cancer communications (London, England) [Cancer Commun (Lond)] 2026 Feb 06; Vol. 46, pp. 0010. Date of Electronic Publication: 2026 Feb 06 (Print Publication: 2026).
Publication Type: Letter
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: eCollection Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41659918
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vidal-Sabanés+M%22">Vidal-Sabanés M</searchLink>; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Navaridas+R%22">Navaridas R</searchLink>; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA.<br /><searchLink fieldCode="AU" term="%22Bonifaci+N%22">Bonifaci N</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gay-Rua+A%22">Gay-Rua A</searchLink>; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Ortega-Peinado+D%22">Ortega-Peinado D</searchLink>; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Egea+J%22">Egea J</searchLink>; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Encinas+M%22">Encinas M</searchLink>; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Matias-Guiu+X%22">Matias-Guiu X</searchLink>; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.; Oncologic Pathology Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Llobet-Navas+D%22">Llobet-Navas D</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dolcet+X%22">Dolcet X</searchLink>; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101723675%22">Cancer communications (London, England)</searchLink> [Cancer Commun (Lond)] 2026 Feb 06; Vol. 46, pp. 0010. <i>Date of Electronic Publication: </i>2026 Feb 06 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101723675 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2523-3548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225233548%22">25233548 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Commun (Lond) <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41659918
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.34133/cancomm.0010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 0010
    Titles:
      – TitleFull: Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vidal-Sabanés M
      – PersonEntity:
          Name:
            NameFull: Navaridas R
      – PersonEntity:
          Name:
            NameFull: Bonifaci N
      – PersonEntity:
          Name:
            NameFull: Gay-Rua A
      – PersonEntity:
          Name:
            NameFull: Ortega-Peinado D
      – PersonEntity:
          Name:
            NameFull: Egea J
      – PersonEntity:
          Name:
            NameFull: Encinas M
      – PersonEntity:
          Name:
            NameFull: Matias-Guiu X
      – PersonEntity:
          Name:
            NameFull: Llobet-Navas D
      – PersonEntity:
          Name:
            NameFull: Dolcet X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 02
              Text: 2026 Feb 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2523-3548
          Numbering:
            – Type: volume
              Value: 46
          Titles:
            – TitleFull: Cancer communications (London, England)
              Type: main
ResultId 1